Table 1:

Characteristics of Study Participants at First Study Visit (‘pre’ time point)

Subject ID	Group	Age*	Height (cm)*	Weight (kg)*	pKAM (Nm)*
1	Control	16	171	60.2	−21.60
2	Control	16	164	60.3	−7.24
3	Control	17	168	49.7	−3.38
4	Control	16	170	57.0	−8.44
5	Control	17	163	62.4	−3.60
6	Control	16	160	51.3	−6.66
7	Control	15	169	81.6	−25.31
8	Control	16	166	68.2	−6.15
9	Control	16	159	59.4	−25.62
10	Control	17	162	50.6	−13.25
11	Control	17	157	52.2	−5.09
12	Control	15	163	64.6	−4.79
13	Control	17	158	56.8	−13.60
14	aNMT	16	173	63.9	0.97
15	aNMT	16	169	53.6	−15.37
16	aNMT	16	171	58.6	−16.33
17	aNMT	15	168	68.7	−33.11
18	aNMT	17	170	58.5	−21.43
19	aNMT	15	174	54.5	−13.87
20	aNMT	17	170	52.9	−32.26
21	aNMT	16	166	57.6	−22.20
22	aNMT	15	165	66.8	−17.81
23	aNMT	14	155	45.4	−12.43
24	aNMT	16	168	59.9	−14.24
25	aNMT	14	151	40.9	−17.74
26	aNMT	15	158	43.6	−19.02
27	aNMT	15	162	49.8	−6.49
28	aNMT	17	161	57.3	−1.48
29	aNMT	16	167	73.8	−40.52
30	aNMT	17	169	87.9	−34.43

aNMT: augmented neuromuscular training

pKAM: peak knee abduction movement (bilateral average of three trials)

^*No significant between-group differences (all p > .05; two-tailed)